Journal article icon

Journal article

Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system

Abstract:
The Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) has recently emerged as a leading candidate antigen against the blood-stage human malaria parasite. However it has proved challenging to identify a heterologous expression platform that can produce a soluble protein-based vaccine in a manner compliant with current Good Manufacturing Practice (cGMP). Here we report the production of full-length PfRH5 protein using a cGMP-compliant platform called ExpreS2, based on a Drosophila melanogaster Schneider 2 (S2) stable cell line system. Five sequence variants of PfRH5 were expressed that differed in terms of mutagenesis strategies to remove potential N-linked glycans. All variants bound the PfRH5 receptor basigin and were recognized by a panel of monoclonal antibodies. Analysis following immunization of rabbits identified quantitative and qualitative differences in terms of the functional IgG antibody response against the P. falciparum parasite. The antibodies induced by one protein variant were shown to be qualitatively similar to responses induced by other vaccine platforms. This work identifies Drosophila S2 cells as a clinically-relevant platform suited for the production of 'difficult-to-make' proteins from Plasmodium parasites, and identifies a PfRH5 sequence variant that can be used for clinical production of a non-glycosylated, soluble full-length protein vaccine immunogen.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1038/srep30357

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Jenner Institute
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Jenner Institute
Role:
Author


More from this funder
Funding agency for:
Draper, S
Grant:
Senior Fellow [grant number 106917/Z/15/Z]
More from this funder
Funding agency for:
Draper, S
Grant:
Senior Fellow [grant number 106917/Z/15/Z]
More from this funder
Funding agency for:
Alanine, D
Grant:
iCASE PhD Studentship [MR/K017632/1
MR/K025554/1
More from this funder
Funding agency for:
Illingworth, J
Douglas, A
Higgins, M
Draper, S
Grant:
TranslationalMedicinePhDProgramme [092873/z/10/z
Infection,Immunology
Training Fellowship for Clinicians in Basic Sciences [089455/2/09/z
Senior Fellow [grant number 106917/Z/15/Z]
More from this funder
Grant:
(FP7/2007-2013) [Grant agreement No. 242095]


Publisher:
Nature Publishing Group
Journal:
Scientific Reports More from this journal
Volume:
6
Article number:
30357
Publication date:
2016-01-01
Acceptance date:
2016-07-04
DOI:
EISSN:
2045-2322


Pubs id:
pubs:631751
UUID:
uuid:b447e5a9-295b-4b97-96b3-119ea648fcdb
Local pid:
pubs:631751
Source identifiers:
631751
Deposit date:
2016-07-04

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP